(Q77639216)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

main subject

phase II clinical trial

1 reference

1 reference

George Koumakis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Matina Demiri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Vassilios Barbounis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Michail Vassilomanolakis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Emmanuel Gontikakis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Philip Pamouksoglou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Jabrahel Dahabre

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Anna P Efremidis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

315-317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900441-X

7 January 2021

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900441-X

7 January 2021

A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. The European Lung Cancer Working Party. 101473.1044@compuserve.com

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900441-X

7 January 2021

Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900441-X

7 January 2021

10.1016/S0169-5002(01)00441-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11844607%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference